tbuckley/cabot-search huggingface dataset:
Clinical and Molecular Characterization of TP53-Mutant Acute Lymphoblastic Leukemia
Authors: Ethan Harris, Madina Sukhanova, Yasmin Abaza, Yenny Alejandra Moreno Vanegas, Talha Badar, Chenyu Lin, Alexander Coltoff, Anand Ashwin Patel, Peng Wang, Melissa Tjota, Jason Xiaojun Cheng, Sandeep Gurbuxani, Girish Venkataraman, Daniel A. Arber, Adam S Duvall, Michael W Drazer, Richard A. Larson, Olatoyosi Odenike, Bijal D Shah, Wendy Stock, Ibrahim Aldoss, Caner Saygin
Journal: Blood (2024)
Evaluating the Safety of Tyrosine Kinase Inhibitor Discontinuation in Adult Patients with Ph+ ALL Not Undergoing Allogeneic Transplant
Authors: Eitan Kugler, Niranjan Shiwaji Khaire, Elias Jabbour, Nicholas J. Short, Tapan M. Kadia, Fadi G. Haddad, Koji Sasaki, Rashmi Kanagal-Shamanna, Rebecca Garris, Farhad Ravandi, Hagop M. Kantarjian, Nitin Jain
Journal: Blood (2024)
The Efficacy and Safty of Chidamide and Azacitidine Combined with Chemotherapy As a First-Line Treatment in T Follicular Helper Lymphomas: A Comprehensive Retrospective Study
Authors: Chen Xia, Yajun Li, Zhongyi Sun, Lijun Huang, Ruolan Zeng, Yizi He, Caiqin Wang, Ling Xiao, Hui Zhou
Journal: Blood (2024)
Minimal Residual Disease-Guided Combination of Ibrutinib and Venetoclax Compared to FCR in Untreated Patients with CLL of Intermediate Risk : Final Results of the Eradic Trial from the Filo Group
Authors: Anne Sophie Michallet, Remi Letestu, Magali Legarff, Stéphane Morisset, Therese Aurran-Schleinitz, Kamel Laribi, Vincent Levy, Laurence Simon, Damien Roos Weil, Marie Sarah Dilhuydy, Cecile Tomowiak, Caroline Dartigeas, Romain Guieze, Olivier Tournilhac, Emmanuelle Ferrant, Sophie De Guibert, Pierre Feugier, Fatiha Merabet, Stéphane Lepretre, Philippe Carassou, Julie Gay, Benedicte Hivert, Luc-Matthieu Fornecker, Jehan Dupuis, Lysiane Molina, Bruno Villemagne, Guillaume Cartron, Bernard Drenou, Omar Benbrahim, Xavier Cahu, Florence Nguyen Khac, Valerie Rouillé, Loic Ysebaert, Anne Quinquenel
Journal: Blood (2024)
Using Polatuzumab Plus Chemotherapy for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Real-World Study from the Grupo De Estudio De Linfoproliferativos De Latinoamerica (GELL)
Authors: Luis Mario Villela Martinez, Brady Beltran, Alberto Villalobos Prieto, Ana Carolina Oliver, Marcela Elizabeth Zamora Matute, Maria Alejandra Torres Viera, Alana Von Glasenapp, Yusaima Rodriguez-Fraga, Victoria Irigoin, Sabrina Ranero Ferrari, Maria Orlova, German R. Stemmelin, Sofía Gabriela Rivarola, Adrían Alejandro Ceballos López, Jorge Montemayor, Martha Alvarado Ibarra, Alonso Hernandez, Daniela De Jesus Perez Samano, Álvaro Cabrera García, Natalia Pin Chuen Zing, Myrna Candelaria, Henry Idrobo, Guilherme Fleury Perini, Rosa Oliday, Breno Gusmao, Juan Daniel Garza Escobar, Marcelo Pitombeira de Lacerda, Sally Paredes, Virginia Lema Spinelli, Humberto Martinez-Cordero, Rafael Martin De Jesus Pichardo Rodriguez, Luis Enrique Malpica Castillo, Jorge J. Castillo
Journal: Blood (2024)
Phase III COMMODORE 2 and 1 Trials: Characterization of Breakthrough Hemolysis Events in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Treated with Crovalimab or Eculizumab
Authors: Austin G. Kulasekararaj, Jaroslaw Czyz, Catherine Flynn, Gabriela Roncone Gastal, Marek Hus, Chrysavgi Lalayanni, Erfan Nur, Phillip Scheinberg, Yasutaka Ueda, Alessandro Maria Vannucchi, Maria Vidriales Vicente, Iige Viigimaa, Simon Buatois, Alice C. Chang, Sammy Chebon, Alexander Röth
Journal: Blood (2024)
Heme-Mediated Tau Phosphorylation Is Critical for Neuroaxonal Damage and Cognitive Impairment in Sickle Cell Disease
Authors: Nandinii Sekar, Shane C Lenhart, Paritosh Mondal, Lesley Foley, Samit Ghosh, Enrico M Novelli, T Kevin Hitchens, Xiaoming Hu, Rimi Hazra
Journal: Blood (2024)
Selectivity and Long Action of <i>In Vivo</i> Efficacy of CS585, a Novel Prostacyclin Receptor Agonist, Compared to FDA-Approved Prostacyclin Agonists Iloprost and Selexipag in the Prevention of Thrombosis
Authors: Livia Stanger, Mariane Flores, Krista A Goerger, Bjorn Dahlof, Michael Holinstat
Journal: Blood (2024)
Accuracy of a Bleeding Assessment Tool in Predicting the Diagnosis of an Inherited Bleeding Disorder: Systematic Review and Meta-Analysis
Authors: Ahmad Alhuniti, Heba Abdallah, Margaret L. Rand, Susan Kearney, Anjali A. Sharathkumar, Meera Sridharan, Zhen Wang, Rajiv K Pruthi
Journal: Blood (2024)
Unraveling Molecular Subgroup-Specific Pathway Dependencies in Chronic Lymphocytic Leukemia through Drug-Perturbed Transcriptomic Profiling and Statistical Modeling
Authors: Caroline Lohoff, Thi Huong Lan Do, Ferris Jung, Sandra Kummer, Vladimir Benes, Wolfgang Huber, Thorsten Zenz, Junyan Lu
Journal: Blood (2024)
Asciminib Provides Long-Term, Durable Molecular Responses in Patients with T315I-Mutated CML-CP: Final Analysis from a Phase 1 Trial
Authors: Jorge E. Cortes, Delphine Rea, Michael J. Mauro, Andreas Hochhaus, Dong-Wook Kim, Koji Sasaki, Fabian Lang, Michael C. Heinrich, Massimo Breccia, Michael W. Deininger, Yeow Tee Goh, Jeroen J.W.M. Janssen, Moshe Talpaz, Valle Gomez G De Soria, Philipp le Coutre, Francois-Xavier Mahon, Daniel Deangelo, Shruti Kapoor, Gessami Sanchez-Olle, Meng Cao, Nithya Agrawal, Timothy P Hughes
Journal: Blood (2024)
Consistently High 5.5-Year Progression-Free Survival (PFS) Rates in Patients with and without Bulky Baseline Lymphadenopathy ≥5 Cm Are Associated with High Undetectable Minimal Residual Disease (uMRD4) Rates after First-Line Treatment with Fixed-Duration Ibrutinib + Venetoclax for Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) in the Phase 2 CAPTIVATE Study
Authors: William G. Wierda, Ryan Jacobs, Paul M Barr, John N. Allan, Tanya Siddiqi, Alessandra Tedeschi, Thomas J. Kipps, Susan M. O'Brien, Xavier C. Badoux, Andrea Visentin, Masa Lasica, Dennis A. Carney, Anna Elinder Cambrun, Javier De la Serna, Edith Szafer Glusman, Cathy Zhou, Jutta K. Neuenburg, Lynne Neumayr, Anita Szoke, James P. Dean, Paolo Ghia, Constantine S. Tam
Journal: Blood (2024)
Analysis of Outcomes after Second Allogeneic Stem Cell Transplant in Relapsed Acute Myeloid Leukaemia in Children: A Study from the EBMT Pediatric Diseases Working Party
Authors: Nimrod Buchbinder, Victor Michel, Mouad Abouqateb, Arnaud Dalissier, Katharina Kleinschmidt, Marc Ansari, Franco Locatelli, Alexey Maschan, Robert Wynn, Franca Fagioli, Marco Zecca, Charlotte Jubert, Marc Bierings, Petr Sedlacek, Alexander Kulagin, Marta González Vicent, Alessandra Biffi, Gerard Michel, Oana Mirci-Danicar, Wolfgang Holter, Jacques-Emmanuel Galimard, Pascale Schneider, Krzysztof Kalwak
Journal: Blood (2024)
Integrating Genomic &amp; Transcriptomic Features for Noninvasive Detection, Characterization, and Monitoring of T-Cell Lymphomas
Authors: Takeshi Sugio, Monica Nesselbush, Navika Shukla, Andrea Garofalo, Jurik A. Mutter, Mohammad Shahrokh Esfahani, Stefan K. Alig, Shuyu Shi, Troy Noordenbos, Mark P. Hamilton, Cedric Rossi, Feng Tian, Chih Long Liu, Mari Olsen, Xiaoman Kang, David A Russler-Germain, Steven Horwitz, Koji Kato, Ayumu Ito, Makoto Yamagishi, Takahiro Fukuda, Koichi Akashi, Kaoru Uchimaru, Michael S. Khodadoust, Maximilian Diehn, Neha Mehta-Shah, Ash A. Alizadeh
Journal: Blood (2024)
Prognostic Impact of the Genetic Risk at Baseline Associated to the MRD Clearance in Adult Patients with Newly Diagnosed Acute Lymphoblastic Leukemia. Preliminary Results of Pethema LAL19 Trial
Authors: Anna Torrent, Mireia Morgades, Beatriz Soriano, Jordi Ribera, Susana Barrera, Pau Montesinos, Eulàlia Genescà, José González-Campos, Pere Barba, Jordi Esteve, Marta Sitges, Maria Paz Queipo De Llano, Carmen Botella, Clara Maluquer Artigal, Irene García-Cadenas, Marisa Calabuig, Alberto Hernández Sánchez, Laura Torres, Isabel Granada, Jesus Maria Hernandez Rivas, Alberto Orfao, Josep-Maria Ribera
Journal: Blood (2024)
Venetoclax Combined with Cladribine, Idarubicin, Cytarabine (CLIA) Results in Higher Remission Rates over Conventional 7+3 Chemotherapy without Increased Toxicity in Newly Diagnosed Acute Myeloid Leukemia
Authors: Benjamin J. Lee, Shawn P. Griffin, Jean Doh, Stefan O. Ciurea, Piyanuch Kongtim, Deepa Jeyakumar, Kiran Naqvi
Journal: Blood (2024)
<i> <i>DNMT3A</i> </i> Mutant Clonal Hematopoiesis in Vexas Syndrome Epigenetically Potentiates IL-13 and IL-15 Inflammatory Pathways and Is Associated with Increased Mortality
Authors: Jenna A. Fernandez, Yael Kusne, Fernanda Gutierrez-Rodrigues, Bhavisha A. Patel, Christy Finke, Emma M. Groarke, Matthew J Koster, Abhishek A. Mangaonkar, Naseema Gangat, Kenneth Warrington, Kaaren K. Reichard, Horatiu Olteanu, David Viswanatha, Rong He, Megan Sullivan, Kambiz Kalantari, Alexander Hines, Daniel Montes, Neal S. Young, David B Beck, Wazim Ismail Mohammed, Alexandre Gaspar-Maia, Terra L. Lasho, Mrinal M. Patnaik
Journal: Blood (2024)
Age-Related Cellular Factors Facilitate TET2 Mutant Clonal Hematopoiesis
Authors: Daniel J Vail, Dongxu Jiang, Kunho Chung, Yahan Zhang, Sophia Martinez, Luca Guarnera, Yvonne Parker, J. Joseph Melenhorst, Daniel Lindner, Jaroslaw Maciejewski, Babal K. Jha
Journal: Blood (2024)
Rap-536, a Murine Luspatercept Analog Ameliorates Anemia and Vaso-Occlusion in Experimental Model of Sickle Cell Disease
Authors: Thiago Trovati Maciel, Haoua M Bazoum, Rachel Rignault-Bricard, Shikha Saini, Isabelle Chevalme, Sara El Hoss, Robert Li, Slimane Allali, Rajasekhar N.V.S. Suragani, Olivier Hermine
Journal: Blood (2024)
PI3K-AKT Pathway Mediates the Imbalance of Macrophage Polarization in Immune Thrombocytopenia Patients
Authors: Mengzhu Shen, Hong-Yan Zhao, Dan-Dan Chen, Xiao-Dong Mo, Yuan-Yuan Zhang, Ya-Zhe Wang, Xiaohui Zhang, Xiao-Jun Huang, Yuan Kong
Journal: Blood (2024)
CCL8/CCL13-Producing Tumor-Associated Macrophages Linked to Poor Outcomes after CAR T Cell Therapy for LBCL
Authors: Kelvin C. Mo, Christine Y. Yeh, Mark P. Hamilton, Jay Spiegel, Moksha Desai, Zachary Ehlinger, Warren D. Reynolds, Eric Yang, Michael G. Ozawa, Yiyun Chen, Snehit Prabhu, Matthew J. Frank, Lori Muffly, Gursharan K. Claire, Sushma Bharadwaj, Saurabh Dahiya, Katherine A. Kong, Elena Sotillo, Bita Sahaf, Sylvia Plevritis, David B. Miklos, Crystal L. Mackall, Zinaida Good
Journal: Blood (2024)
The Amyloidogenic Transthyretin V122I Variant Increase Severity of Cardiac Phenotype and Mortality in Sickle Cell Disease
Authors: Haiou Li, Xunde Wang, Nancy Asomaning, Anna Conrey, Britney Kruah, Kylie Haymaker, Colin O. Wu, Vandana Sachdev, Swee Lay Thein
Journal: Blood (2024)
Declining Autophagic Flux Underlies Mitochondrial and Platelet Defects in Aging
Authors: Guadalupe Rojas-Sanchez, Jorge Calzada-Martinez, Orlando Esparza, Giovanny Hernandez, Gabriela Dveksler, Ken Jones, Lucas Ting, Catherine Jankowski, Marguerite Kelher, Marilyn Manco-Johnson, Andrew Thorburn, Paola Maycotte, José A López, Pavel Davizon-Castillo
Journal: Blood (2024)
High Mobility Group A1 (HMGA1) Chromatin Regulators Maintain Quiescent, Regenerative HSC By Repressing IGF1 Networks That Promote Stem Cell Aging
Authors: Zanshe Thompson, Li Z Luo, Liping Li, Bowen Wang, Jung-Hyun Kim, Lingling Xian, Bailey West, Leslie Cope, John Lister, Linda Resar
Journal: Blood (2024)
Preliminary Results from a Phase 1b Study of Non-Covalent Pan-Mutant BTK Inhibitor Docirbrutinib (AS-1763) in Patients with Previously Treated B-Cell Malignancies
Authors: Nitin Jain, Catherine C. Coombs, James D'Olimpio, Nirav N. Shah, Jacqueline C. Barrientos, Seung Tae Lee, Andrew Gillis-Smith, Shuo Ma, Shirou Kirita, Masaaki Sawa, Kyoko Miyamoto, Akinori Arimura, William G. Wierda, Varsha Gandhi, Javier Pinilla-Ibarz
Journal: Blood (2024)
Site-Specific Analysis of Extranodal Involvement Reveals Distinct Efficacy Outcomes with CAR T-Cell Therapy in Large B-Cell Lymphoma Patients
Authors: Gloria Iacoboni, Kai Rejeski, Victor Navarro Garces, Tom van Meerten, Alex Rampotas, Ana Africa Martin Lopez, Juan Luis Reguera, Mariana Bastos-Oreiro, Claire Roddie, Ana Benzaquen, Cecilia Carpio, Javier Delgado Serrano, Maria Landwehr, Sophia Stock, Pablo Silva De Tena, Pau Abrisqueta Costa, Janneke W. De Boer, Lucia Lopez Corral, Rafael Hernani, Marion Subklewe, Mi Kwon, Maeve O'Reilly, Pere Barba
Journal: Blood (2024)
Liver Steatosis and Metabolic Toxicities in Acute Lymphoblastic Leukemia Adults Undergoing Asparaginase-Based Therapy: Findings from a Non-Invasive Assessment Study
Authors: Fausto A Rios-Olais, Alicia K Pérez-Rojas, Ivan Arnaud-Borboa, Analy Mora, Guillermo Rosales-Sotomayor, Jonahi S Serrano-Heredia, Juan Luis Ontiveros-Austria, Juan Rangel-Patiño, Roberta Demichelis
Journal: Blood (2024)
Prognostic Value of t(11;14)(q13;32) in Newly Diagnosed Myeloma Patients in Novel Agent Era; Matched-Pair Analysis
Authors: Yuka Shimada, Daisuke Miura, Ami Inokuchi, Daisuke Ikeda, Rikako Tabata, Kentaro Narita, Masami Takeuchi, Kosei Matsue
Journal: Blood (2024)
Nivolumab in Combination with Dose Adjusted (DA) R-EPOCH for First-Line Treatment of Large B-Cell Lymphoma: Results from a Phase II Trial
Authors: David A. Bond, Ying Huang, John C. Reneau, Yazeed Sawalha, Jonathan E. Brammer, Timothy Voorhees, Narendranath Epperla, Audrey M. Sigmund, Lapo Alinari, Walter Hanel, Anna Gilmore, Misty Fleming, Kathleen Stamper, Robert Baiocchi, Beth Christian, Kami J. Maddocks
Journal: Blood (2024)
CAR-Tography: Longitudinal Mapping of CAR-T Toxicities across B-Cell Malignancies Reveals Biologically Distinct and Prognostically Relevant Toxicity Phenotypes
Authors: Kai Rejeski, Teng Fei, Alejandro Luna, Mohammad Alhomoud, Yannis K. Valtis, Noriko Nishimura, Marina Gomez-Llobell, Noa Golan Accav, Ofrat Beyar-Katz, Sandeep S. Raj, Magdalena Corona, Alfredo Rivas-Delgado, Hamza Hashmi, Sridevi Rajeeve, Efrat Luttwak, Michael Scordo, Gunjan L. Shah, Maria Lia Palomba, Michael von Bergwelt-Baildon, Marion Subklewe, Abraham Avigdor, Ronit Marcus, Avichai Shimoni, Arnon Nagler, Tsila Zuckerman, Jabour Halloun, Uri Greenbaum, Sham Mailankody, Saad Z. Usmani, Gilles Salles, Jae H. Park, Miguel Angel Perales, Roni Shouval
Journal: Blood (2024)
Pharmacodynamic Signatures and Correlatives of Response in Patients with Relapsed/Refractory Multiple Myeloma (RRMM) Treated with Talquetamab or Teclistamab Plus Daratumumab and Pomalidomide
Authors: Deeksha Vishwamitra, Sheri Skerget, Diana Cortes, Kalpana Bakshi, Lien Vandenberk, Weili Sun, Jaszianne Tolbert, Colleen Kane, Hein Ludlage, Bas D Koster, Julie S Larsen, Tobias Kampfenkel, Ching Li, Farheen Zishan, Thomas Prior, Luciano J. Costa, Jesus G Berdeja, Cyrille Touzeau, Aurore Perrot, Emma Searle, Jeffrey V Matous, Ajai Chari, Donna Reece, Manisha Bhutani, Bhagirathbhai Dholaria, Anita D'Souza, Thomas G Martin, John T. McKay, Alfred L Garfall, Amrita Y Krishnan, Niels W.C.J. van de Donk, Nizar J. Bahlis, Ricardo M. Attar
Journal: Blood (2024)
Second-Line Bosutinib Is Effective and Feasible in Patients Failing Second Generation TKI (2G-TKI) in Chronic Phase Chronic Myeloid Leukemia (CML) - an Analysis of a Subcohort of the Bodo Trial (CML-VII-study of the German CML Study Group)
Authors: Susanne Isfort, Kirsi Manz, Lino L. Teichmann, Martina Crysandt, Andreas Burchert, Andreas Hochhaus, Susanne Saussele, Alexander Kiani, Joachim R. Goethert, Thomas Illmer, Philippe Schafhausen, Haifa Kathrin Al-Ali, Frank Stegelmann, Mathias Hänel, Tim Pfeiffer, Aristoteles Giagounidis, Georg-Nikolaus Franke, Steffen Koschmieder, Alice Fabarius, Thomas Ernst, Mareille Warnken-Uhlich, Denise Kohn, Markus Pfirrmann, Dominik Wolf, Tim H. H. Brummendorf
Journal: Blood (2024)
Bendamustine in Combination with Gemcitabine and Vinorelbine As Salvage Regimen for Relapsed or Refractory Peripheral T-Cell Lymphomas: A Retrospective Single Center Experience
Authors: Filippo Bagnoli, Jacopo Calabrese De Feo, Francesca Livia Letizia Ricci, Jacopo Mariotti, Barbara Sarina, Monica Balzarotti, Daniela Taurino, Daniele Mannina, Chiara De Philippis, Daoud Rahal, Arturo Bonometti, Massimo Magagnoli, Rita Mazza, Marcello Rodari, Laura Giordano, Stefania Bramanti, Carmelo Carlo-Stella, Armando Santoro
Journal: Blood (2024)
Phase II Prospective Trial of Fixed Duration Obinutuzumab, Ibrutinib and, Venetoclax in an Elderly Cohort of Patients with Richter's Syndrome-Givers Regimen
Authors: Tamar Tadmor, Ohad Benjamini, Neta Goldschmidt, Natalia Kreiniz, Osnat Bairey, Reut Harel, Nadav Sarid, Tsofia Levi, Ofir Wolach, Yair Herishanu
Journal: Blood (2024)
Outcome after Allogeneic Stem Cell Transplant in Adults with Inherited Myeloid Malignancies - a Multicenter Retrospective Analysis on Behalf of the German Cooperative Transplant Study Group
Authors: Tim Lohmann, Matthias Stelljes, Caroline Pabst, Stefan Klein, Johanna Tischer, Alessia Fraccaroli, Leo Ruhnke, Laura Groneck, Alexander Denk, Friedrich Stölzel, Daniel Wolff, Judith Schaffrath, Fabian Beier, Maher Hanoun, Johannes Schetelig, Martin Bornhäuser, Artur Schneider, Hans Christian Reinhardt, Christina Rautenberg, Thomas Schroeder
Journal: Blood (2024)
Post-Therapeutic Tumor Losses of B-Cell Receptor Components CD20/CD19, a New Challenge in the Management of Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Authors: Thomas Hueso, Jessy Alchidiac, Maria-Rosa Ghigna, Arnaud Pages, Cyril Quivoron, Camille Bigenwald, Loic Renaud, Cristina Castilla-Llorente, Alexandre Eeckhoutte, Serge Bologna, Veronique Morel, Vincent Delwail, Pierre Feugier, Catherine Thieblemont, Olivier Bernard, Peggy Dartigues, Christophe Massard, Vincent Ribrag, Jean-Marie Michot
Journal: Blood (2024)
Intrinsic Immunosuppressive Features of Monocytes Suppress CART19 through IL-1 Pathway Modulation in Mantle Cell Lymphoma
Authors: Kun Yun, R. Leo Sakemura, Ismail Can, Omar Gutierrez Ruiz, Ekene Ogbodo, Shuwen Zhang, Truc Huynh, Claudia Manriquez Roman, Olivia L. Sirpilla, Carli M. Stewart, James H. Girsch, Jennifer M. Feigin, Long K. Mai, Hong Xia, Brooke L. Kimball, Lionel A Kankeu Fonkoua, Mehrdad Hefazi, Michael W. Ruff, Fariborz Rakhshan Rohakhtar, Vernadette Simon, Elizabeth L. Siegler, Mike Mattie, Sao-Mai Nguyen-Mau, Simone Filosto, Saad S. Kenderian
Journal: Blood (2024)
<i>Ex-Vivo</i> Evaluation of Stx-0712, a CCR2 Cytotoxicity Targeting Chimera (CCR2-CyTAC) for the Treatment of Acute Myeloid Leukemia
Authors: Craig Leach, Laura Bertoldi, Sofia Carbajosa, Natalia Cavallo, Alejandra Garcia, Gastón Soria, Yue Wei, Courtney D. DiNardo, Guillermo Montalban-Bravo, Brandon Turunen
Journal: Blood (2024)
Impact of Minimal Residual Disease on Progression-Free Survival in Patients with Newly Diagnosed Multiple Myeloma Treated with Isatuximab, Lenalidomide, Bortezomib and Dexamethasone Induction Therapy in the Phase 3 GMMG-HD7 Trial
Authors: Elias K. Mai, Hans Salwender, Michael Hundemer, Uta Bertsch, Ema Pozek, Axel Benner, Roland Fenk, Britta Besemer, Christine Hanoun, Roland Schroers, Ivana von Metzler, Mathias Hänel, Christoph Mann, Lisa Leypoldt, Bernhard Heilmeier, Stefanie Huhn, Sabine Vogel, Christof Scheid, Igor Wolfgang Blau, Steffen Luntz, Niels Weinhold, Tobias A.W. Holderried, Karolin Trautmann-Grill, Deniz Gezer, Maika Klaiber-Hakimi, Martin Mueller, Evgenii Shumilov, Wolfgang Knauf, Christian Sebastian Michel, Thomas Geer, Hendrik Riesenberg, Christoph Lutz, Marc S. Raab, Martin Hoffmann, Katja C. Weisel, Hartmut Goldschmidt
Journal: Blood (2024)
Beyond Classical Hodgkin Lymphoma: Long-Term Risks and Secondary Cancers-Insights from the Texas Cancer Registry
Authors: Hala Hassanain, Ethan A Burns, Sunil Mathur, Darshil Choksi, Cesar Giancarlo Gentille Sanchez, Chih-Chi Andrew Hu, Mai Hanh, Carrie Yuen, Shilpan S. Shah, Siddhartha Ganguly, Sai Ravi Kiran Pingali
Journal: Blood (2024)
Nonclinical Toxicology, Biodistribution, and Pharmacokinetics of UB-VV111, an <i>In Vivo</i> Anti-CD19 CAR T Cell Therapy
Authors: Alissa H. Brandes, Angela Soo Min Koo, Anai Perez, Kathryn Michels, Travis Friesen, Alyssa Sheih, Don Parilla, Susana Hernandez, Nolan Ericson, Sarah Dickerson, Mason Muhonen, Jessica Freeman, Sarah Gould, Alessandra Maria Sullivan, Jeffrey Teoh, Byoung Y. Ryu, Andrew M. Scharenberg, Ryan P. Larson
Journal: Blood (2024)
Asciminib (ASC) Demonstrates Favorable Safety and Tolerability Compared with Each Investigator-Selected Tyrosine Kinase Inhibitor (IS TKI) in Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP) in the Pivotal Phase 3 ASC4FIRST Study
Authors: Jorge E. Cortes, Andreas Hochhaus, Timothy P Hughes, Jianxiang Wang, Dong-Wook Kim, Dennis Dong Hwan Kim, Jiri Mayer, Yeow Tee Goh, Philipp le Coutre, Gabriel Etienne, Naoto Takahashi, Inho Kim, David Andorsky, Ghayas C. Issa, Felice Bombaci, Shruti Kapoor, Rajendra Jinwal, Lillian Yau, Richard Larson
Journal: Blood (2024)
Comparison of Clinical Characteristics and Prognosis between Aggressive NK-Cell Leukemia and Advanced-Stage Extranodal NK/T-Cell Lymphoma
Authors: Ayumi Fujimoto, Kana Miyazaki, Takeshi Maeda, Kimikazu Yakushijin, Wataru Munakata, Takahiro Fujino, Yasuo Ejima, Nobuhiro Hiramoto, Noriko Fukuhara, Jun Takizawa, Dai Maruyama, Nobuko Kubota, Hideki Goto, Rika Sakai, Senzo Taguchi, Naoko Asano, Fumihiro Ishida, Motoko Yamaguchi, Ritsuro Suzuki
Journal: Blood (2024)
NF-Kb Pathway Activation Driven By TRAF3 Loss Mediates Resistance to Anti-BCMA T-Cell Based Therapies in Multiple Myeloma
Authors: David Jung, Holly Lee, Sejal Chikhale, Mansour Poorebrahim, Sungwoo Ahn, Sacha Benaoudia, Noemie Leblay, Francesco Maura, Nizar J. Bahlis, Paola Neri
Journal: Blood (2024)
Clinical Outcomes of Neonatal Central Line-Related Thrombosis: A Multicentric Retrospective Cohort Study
Authors: Marie-Pier Desjardins, Audrey Hébert, Anie Lapointe, Christine Sabapathy, Alexandra Zabeida, Kriti Kumar, Soumitra Tole, Mihir Bhatt, Mira Liebman, Juliette Déry, Ali Amid, Janie Charlebois, Marc Beltempo, Marie-Claude Pelland-Marcotte
Journal: Blood (2024)
A Novel Mouse Model of Hemoglobin-SC Disease: Bridging the Knowledge Gap in Sickle Cell Disease
Authors: Tahereh Setayesh, Mengna Chi, Zachery Oestreicher, Masahide Sakabe, Xin Mei, Katherine Vandenheuvel, Tim M. Townes, Yueh-Chiang Hu, Punam Malik
Journal: Blood (2024)
KPT-330 Combined with Radiation Therapy: Effective Central Nervous System Lymphoma Treatment with Reduced Neurotoxicity
Authors: Wenzhuo Zhuang, Yuchen Zhang, Chunxiao Yang, Linlin Qin, Ruijing Hu, Menglu Chen, Xinyuan Zhang, Qi Li, Xingping Lang, Si Chen, Bingzong Li
Journal: Blood (2024)
Pralatrexate Is Effective in Cytotoxic Cutaneous T-Cell Lymphomas
Authors: Christina Poh, Jenna M. Voutsinas, Ivan Huang, Edus H. Warren, Caitlin A. Crimp, Mazyar Shadman, Ryan C. Lynch, Brian G. Till, Chaitra S. Ujjani, Mengyang Di, Vikram Raghunathan, Stephen D. Smith, Qian Vicky Wu, Michi M. Shinohara, Ajay K. Gopal
Journal: Blood (2024)
Complementary and Alternative Medicine (CAM) Use Reported Among Individuals with Immune Thrombocytopenia (ITP): Data from the ITP Natural History Study Registry
Authors: Jennifer MacWhirter - DiRaimo, Laura Bou-Maroun, Debbie Jiang, Caroline Kruse, Michele P. Lambert, Cindy Neunert, Allison Remiker, Melissa J Rose, Kevin Won, Rachael F. Grace
Journal: Blood (2024)
Oxygen Gradient Ektacytometry Is Associated with Markers of Hemolysis and Inflammation in a Large Sickle Cell Disease Cohort within the GenoMed4ALL Project
Authors: Amira Idrizovic, Marissa J.M. Traets, Anna Collado Gimbert, Sara Reidel, Sigrid van der Veen, Anne-Laure Pham Hung D'Alexandry D'Orengiani, Mirco D'Agnolo, Emmanuel Adu, Mickael MARIN, Emmanuelle Bourdelier, Elisabetta Mezzalira, Betzabel Cajiao Garcia, Santiago Zazo, Tiziana Sanavia, Cesare Rollo, David Beneitez, Bart J. Biemond, Erfan Nur, Karin Fijnvandraat, Saskia EM Schols, Anita W. Rijneveld, Marjon H. Cnossen, Aida Kidane, Nicolas Hebert, Maria Paola Boaro, Slimane Allali, Caroline Le van kim, Anna Ruiz Llobet, Béatrice Gulbis, Federico Alvarez, Piero Fariselli, Petros Kountouris, Raffaella Colombatti, Pablo Bartolucci, Mariane De Montalembert, Richard van Wijk, Eduard J. Van Beers, Maria del Mar Mañú-Pereira, Minke A.E. Rab
Journal: Blood (2024)